aTYR PHARMA INC Quarterly Current Ratio in % from Q3 2015 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
aTYR PHARMA INC quarterly Current Ratio history and growth rate from Q3 2015 to Q2 2024.
  • aTYR PHARMA INC Current Ratio for the quarter ending June 30, 2024 was 696 %, a 11% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 696 -85.6 -11% Jun 30, 2024
Q1 2024 731 -56.9 -7.21% Mar 31, 2024
Q4 2023 803 -88.6 -9.93% Dec 31, 2023
Q3 2023 800 -405 -33.6% Sep 30, 2023
Q2 2023 782 -796 -50.5% Jun 30, 2023
Q1 2023 788 -727 -48% Mar 31, 2023
Q4 2022 891 -524 -37% Dec 31, 2022
Q3 2022 1.2K +113 +10.4% Sep 30, 2022
Q2 2022 1.58K +905 +135% Jun 30, 2022
Q1 2022 1.52K +912 +151% Mar 31, 2022
Q4 2021 1.42K +924 +188% Dec 31, 2021
Q3 2021 1.09K +693 +174% Sep 30, 2021
Q2 2021 672 +305 +83% Jun 30, 2021
Q1 2021 603 +247 +69.6% Mar 31, 2021
Q4 2020 492 +154 +45.5% Dec 31, 2020
Q3 2020 399 +3.35 +0.85% Sep 30, 2020
Q2 2020 367 -80.2 -17.9% Jun 30, 2020
Q1 2020 356 -145 -28.9% Mar 31, 2020
Q4 2019 338 -236 -41.1% Dec 31, 2019
Q3 2019 396 -268 -40.4% Sep 30, 2019
Q2 2019 448 -313 -41.2% Jun 30, 2019
Q1 2019 500 -270 -35.1% Mar 31, 2019
Q4 2018 574 -258 -31.1% Dec 31, 2018
Q3 2018 663 -178 -21.2% Sep 30, 2018
Q2 2018 761 +20.8 +2.81% Jun 30, 2018
Q1 2018 771 +42.3 +5.81% Mar 31, 2018
Q4 2017 832 +155 +22.9% Dec 31, 2017
Q3 2017 842 +167 +24.8% Sep 30, 2017
Q2 2017 740 -57 -7.15% Jun 30, 2017
Q1 2017 728 -199 -21.4% Mar 31, 2017
Q4 2016 677 -209 -23.6% Dec 31, 2016
Q3 2016 674 -52.5 -7.22% Sep 30, 2016
Q2 2016 797 Jun 30, 2016
Q1 2016 927 Mar 31, 2016
Q4 2015 886 Dec 31, 2015
Q3 2015 727 Sep 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.